ALSET INTERNATIONAL LIMITED

Press Releases Alset International Limited

Equities

40V

SG1AE2000006

Delayed Singapore S.E. Other stock markets 10:04:11 15/05/2024 BST			5-day change	1st Jan Change
0.023 ^SGD	0.00%		0.00%	-32.35%

05-15	Alset International Dissolves Step-Down Subsidiary; Shares Climb 4%	MT
04-30	Alset International Limited Announces Board and Committee Changes	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HILLCREST APPOINTS GENERAL MANAGER TECHNOLOGY DEVELOPMENT	15/09/22	AQ
Alset International Limited establishes Alset Mining Pte. Ltd.	23/03/22	AQ
Alset International Limited establishes Alset Mining Pte. Ltd. to embark on cryptocurrency mining activities	23/03/22	AQ
Equity Listing - Ordinary Shares::LISTING AND QUOTATION OF 251,468,017 NEW SHARES	20/12/21	PU
Hillcrest Petroleum : Appoints General Manager Technology Development	10/11/20	AQ
Singapore eDevelopment : Impact BioMedical to Begin Efficacy Testing of Pan-Coronavirus Vaccine Under New Wholly Owned Subsidiary Innate Immune, Inc.	02/10/20	AQ
Singapore eDevelopment : Impact BioMedical Demonstrates 10-Fold Reduction in Viral Population of COVID-19 in Surface Disinfectant Efficacy Testing of its 3F Antiviral Biofragrance	18/09/20	AQ
Singapore eDevelopment : Impact Biomedical initiates Quantum Research Program to solve the Patent Cliff	27/07/20	AQ
Singapore eDevelopment : Impact Biomedical Achieves COVID-19 Success with Equivir and 3F Biofragrance	24/06/20	AQ
Singapore eDevelopment : Impact Biomedical Announces Publication of COVID-19 Research in Peer-Reviewed Journal	17/06/20	AQ
Singapore eDevelopment : Impact Biomedical and GRDG Sciences Announce Medical Technology Package Valued at USD 1.39 Billion (SGD 1.97 Billion) by Independent Experts	01/06/20	AQ
Singapore eDevelopment : Update on Acquisition of Impact Biomedical, Inc.	27/04/20	AQ
Singapore eDevelopment : Impact Biomedical's Majority Owned Next Generation Medical Technologies Valued at USD 592 Million (SGD 841 Million) by Independent Experts	24/04/20	AQ
Singapore eDevelopment : Impact BioMedical's Linebacker and Equivir inhibit SARS-CoV-2, virus responsible for the COVID-19 outbreak	18/03/20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer